GSK plc (GSK)
After hours:
| Previous close | 43.11 |
| Open | 43.16 |
| Bid | 42.75 x 2900 |
| Ask | 43.03 x 1100 |
| Day's range | 42.95 - 43.44 |
| 52-week range | 33.67 - 45.93 |
| Volume | |
| Avg. volume | 3,531,950 |
| Market cap | 87.718B |
| Beta (5Y monthly) | 0.31 |
| PE ratio (TTM) | 14.63 |
| EPS (TTM) | 2.94 |
| Earnings date | 30 Oct 2024 |
| Forward dividend & yield | 1.53 (3.56%) |
| Ex-dividend date | 16 Aug 2024 |
| 1y target est | 46.07 |
ZacksBioNTech (BNTX) Stock Jumps 5.8%: Will It Continue to Soar?
BioNTech (BNTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Yahoo Finance UKTop fund picks for self-invested pensions
For those wanting a bit more control over their retirement pot, a self-invested personal pension (SIPP) could be the way to go.
BloombergBuyout Firm GTCR Is in Advanced Talks to Acquire German Drugmaker Stada
(Bloomberg) -- Buyout firm GTCR is in advanced talks on a potential acquisition of German generic drugmaker Stada Arzneimittel AG, people with knowledge of the matter said. Most Read from BloombergHow Americans Voted Their Way Into a Housing CrisisAfter a Record Hot Summer, Pressure Grows for A/C MandatesChicago Halts Hiring as Deficit Tops $1 Billion Through 2025UC Berkeley Gives Transfer Students a Purpose-Built Home on CampusFor Tenants, AI-Powered Screening Can Be a New Barrier to HousingGTC
